Unknown

Dataset Information

0

An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium.


ABSTRACT: Lipid II is an essential precursor for bacterial cell wall biosynthesis and thereby an important target for various antibiotics. Several lanthionine-containing peptide antibiotics target lipid II with lanthionine-stabilized lipid II binding motifs. Here, we used the biosynthesis system of the lantibiotic nisin to synthesize a two-lipid II binding motifs-containing lantibiotic, termed TL19, which contains the N-terminal lipid II binding motif of nisin and the distinct C-terminal lipid II binding motif of one peptide of the two-component haloduracin (i.e., HalA1). Further characterization demonstrated that (i) TL19 exerts 64-fold stronger antimicrobial activity against Enterococcus faecium than nisin(1-22), which has only one lipid II binding site, and (ii) both the N- and C-terminal domains are essential for the potent antimicrobial activity of TL19, as evidenced by mutagenesis of each single and the double domains. These results show the feasibility of a new approach to synthesize potent lantibiotics with two different lipid II binding motifs to treat specific antibiotic-resistant pathogens.

SUBMITTER: Zhao X 

PROVIDER: S-EPMC7269505 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium.

Zhao Xinghong X   Yin Zhongqiong Z   Breukink Eefjan E   Moll Gert N GN   Kuipers Oscar P OP  

Antimicrobial agents and chemotherapy 20200521 6


Lipid II is an essential precursor for bacterial cell wall biosynthesis and thereby an important target for various antibiotics. Several lanthionine-containing peptide antibiotics target lipid II with lanthionine-stabilized lipid II binding motifs. Here, we used the biosynthesis system of the lantibiotic nisin to synthesize a two-lipid II binding motifs-containing lantibiotic, termed TL19, which contains the N-terminal lipid II binding motif of nisin and the distinct C-terminal lipid II binding  ...[more]

Similar Datasets

2017-02-04 | GSE94507 | GEO
| S-EPMC6893902 | biostudies-literature
| S-EPMC7860584 | biostudies-literature
2020-11-25 | GSE115009 | GEO
| S-EPMC3584866 | biostudies-other
| S-EPMC5404537 | biostudies-literature
| S-EPMC3993680 | biostudies-literature
| S-EPMC151725 | biostudies-literature
| S-EPMC6532320 | biostudies-literature
| S-EPMC10616195 | biostudies-literature